These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19777388)

  • 1. Clinical presentation and long-term outcome of cerebral venous thrombosis.
    English JD; Fields JD; Le S; Singh V
    Neurocrit Care; 2009 Dec; 11(3):330-7. PubMed ID: 19777388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral venous thrombosis: clinical features, risk factors, and long-term outcome in a Tunisian cohort.
    Sidhom Y; Mansour M; Messelmani M; Derbali H; Fekih-Mrissa N; Zaouali J; Mrissa R
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1291-5. PubMed ID: 24462460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial venous hemodynamics is a factor related to a favorable outcome in cerebral venous thrombosis.
    Stolz E; Gerriets T; Bödeker RH; Hügens-Penzel M; Kaps M
    Stroke; 2002 Jun; 33(6):1645-50. PubMed ID: 12053005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.
    Yaghi S; Shu L; Bakradze E; Salehi Omran S; Giles JA; Amar JY; Henninger N; Elnazeir M; Liberman AL; Moncrieffe K; Lu J; Sharma R; Cheng Y; Zubair AS; Simpkins AN; Li GT; Kung JC; Perez D; Heldner M; Scutelnic A; Seiffge D; Siepen B; Rothstein A; Khazaal O; Do D; Kasab SA; Rahman LA; Mistry EA; Kerrigan D; Lafever H; Nguyen TN; Klein P; Aparicio H; Frontera J; Kuohn L; Agarwal S; Stretz C; Kala N; El Jamal S; Chang A; Cutting S; Xiao H; de Havenon A; Muddasani V; Wu T; Wilson D; Nouh A; Asad SD; Qureshi A; Moore J; Khatri P; Aziz Y; Casteigne B; Khan M; Cheng Y; Mac Grory B; Weiss M; Ryan D; Vedovati MC; Paciaroni M; Siegler JE; Kamen S; Yu S; Leon Guerrero CR; Atallah E; De Marchis GM; Brehm A; Dittrich T; Psychogios M; Alvarado-Dyer R; Kass-Hout T; Prabhakaran S; Honda T; Liebeskind DS; Furie K
    Stroke; 2022 Mar; 53(3):728-738. PubMed ID: 35143325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of recanalization on long-term neurological outcome after cerebral venous thrombosis.
    Rezoagli E; Martinelli I; Poli D; Scoditti U; Passamonti SM; Bucciarelli P; Ageno W; Dentali F
    J Thromb Haemost; 2018 Apr; 16(4):718-724. PubMed ID: 29341411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation delay does not affect the functional outcome of cerebral venous thrombosis.
    Ji K; Wu L; Zhao W; Wu C; Xu Y; Duan J; Meng R; Yan F; Chen J; Wu D; Luo Y; Ji X
    Aging (Albany NY); 2020 Jun; 12(12):11835-11842. PubMed ID: 32554865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases.
    Cumurciuc R; Crassard I; Sarov M; Valade D; Bousser MG
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1084-7. PubMed ID: 16024884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and  literature review.
    Alet M; Ciardi C; Alemán A; Bandeo L; Bonardo P; Cea C; Cirio J; Cossio J; Cuculic M; Esnaola MM; García-Pérez F; Giner F; Gómez-Schneider M; Isaac C; Lepera S; Martínez C; Martínez-Lorenzín R; Montes M; Orzuza G; Persi G; Povedano G; Pujol-Lereis V; Quiroga-Narváez J; Romano M; Sabio R; Viglione J; Zurrú MC; Saposnik G;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105145. PubMed ID: 32912503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.
    Viegas LD; Stolz E; Canhão P; Ferro JM
    Cerebrovasc Dis; 2014; 37(1):43-50. PubMed ID: 24356180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation.
    Aguiar de Sousa D; Lucas Neto L; Arauz A; Sousa AL; Gabriel D; Correia M; Gil-Gouveia R; Penas S; Carvalho Dias M; Correia MA; Carvalho M; Canhão P; Ferro JM
    Stroke; 2020 Apr; 51(4):1174-1181. PubMed ID: 32114929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of anticoagulation status on recanalization and outcome of cerebral venous thrombosis.
    Dubey AK; Kalita J; Chaudhary SK; Misra UK
    J Clin Neurosci; 2021 Jul; 89():43-50. PubMed ID: 34119293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.
    Ferro JM; Coutinho JM; Dentali F; Kobayashi A; Alasheev A; Canhão P; Karpov D; Nagel S; Posthuma L; Roriz JM; Caria J; Frässdorf M; Huisman H; Reilly P; Diener HC;
    JAMA Neurol; 2019 Dec; 76(12):1457-1465. PubMed ID: 31479105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apixaban for the treatment of cerebral venous thrombosis: A case series.
    Rao SK; Ibrahim M; Hanni CM; Suchdev K; Parker D; Rajamani K; Mohamed W
    J Neurol Sci; 2017 Oct; 381():318-320. PubMed ID: 28991706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progression of cerebral venous thromboses. A retrospective study].
    Rodier G; Schlück E; Derouiche F; Bronner P; Boulay C; Courtois S; Cohen E
    Presse Med; 2003 May; 32(16):728-33. PubMed ID: 12856530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recanalization and its correlation to outcome after cerebral venous thrombosis.
    Putaala J; Hiltunen S; Salonen O; Kaste M; Tatlisumak T
    J Neurol Sci; 2010 May; 292(1-2):11-5. PubMed ID: 20206363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we have to anticoagulate patients with cerebral venous thrombosis?
    Feher G; Illes Z; Hargroves D; Komoly S
    Int Angiol; 2016 Aug; 35(4):369-73. PubMed ID: 26017760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial.
    Coutinho JM; Zuurbier SM; Bousser MG; Ji X; Canhão P; Roos YB; Crassard I; Nunes AP; Uyttenboogaart M; Chen J; Emmer BJ; Roosendaal SD; Houdart E; Reekers JA; van den Berg R; de Haan RJ; Majoie CB; Ferro JM; Stam J;
    JAMA Neurol; 2020 Aug; 77(8):966-973. PubMed ID: 32421159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting poor response to anti-coagulation therapy in cerebral venous thrombosis using a simple clinical-radiological score.
    Montalvan V; Neves G; Bueso T; Ota R; Bushnaq S; Windisch T; Bushnaq S
    J Clin Neurosci; 2022 Nov; 105():26-30. PubMed ID: 36058024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Cerebral Venous and Sinus Thrombosis: Clinical Course, Imaging Correlates, and Prognosis.
    Kowoll CM; Kaminski J; Weiß V; Bösel J; Dietrich W; Jüttler E; Flechsenhar J; Guenther A; Huttner HB; Niesen WD; Pfefferkorn T; Schirotzek I; Schneider H; Liebig T; Dohmen C
    Neurocrit Care; 2016 Dec; 25(3):392-399. PubMed ID: 27000641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Venous Thrombosis in Hematological Malignancy: Balancing the Risks.
    Pinto MJ; Medeiros PB; Príncipe F; Carvalho M
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104683. PubMed ID: 32059925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.